Breast Cancer

Jay R. Harris, Marc E. Lippman, Umberto Veronesi, Walter Willett

Research output: Contribution to journalReview article

148 Scopus citations

Abstract

Adjuvant Therapy of Breast Cancer The demonstration that adjuvant systemic therapy (i.e., systemic therapy given at the time of primary local treatment in the absence of demonstrated metastases) can prolong the disease-free interval and improve overall survival has been a major advance in the management of breast cancer. Randomized clinical trials of systemic adjuvant therapy were pioneered by the Istituto Nazionale per lo Studio e la Cura dei Tumori176 and the National Surgical Adjuvant Breast and Bowel Project177 and provided the first evidence of the benefit of cytotoxic chemotherapy in women with involvement of axillary lymph nodes, particularly younger women…

Original languageEnglish (US)
Pages (from-to)473-480
Number of pages8
JournalNew England Journal of Medicine
Volume327
Issue number7
DOIs
StatePublished - Aug 13 1992

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Breast Cancer'. Together they form a unique fingerprint.

  • Cite this

    Harris, J. R., Lippman, M. E., Veronesi, U., & Willett, W. (1992). Breast Cancer. New England Journal of Medicine, 327(7), 473-480. https://doi.org/10.1056/NEJM199208133270706